Acupuncture for lung cancer patients on immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This trial tests if adding electroacupuncture at a specific point (ST36, below the knee) to standard chemotherapy and immunotherapy can help people with lung cancer. It aims to improve treatment outcomes and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old
- You must have small cell or non-small cell lung cancer that has spread, and be getting immunotherapy before surgery
- You must be starting standard first-line treatment with chemo plus immunotherapy
- You must be able to take care of yourself (ECOG score 0-2)
- You must have at least one measurable tumor on a CT scan
- You cannot have major health problems like uncontrolled diabetes, severe heart issues, or bleeding disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding electroacupuncture to a PD-1 inhibitor (a type of immunotherapy) can help people with advanced non-small cell lung cancer who have limited activity levels. It may improve treatment response and quality of life.
This trial explores whether adding electroacupuncture (a gentle needle treatment with mild electric pulses) to standard immunotherapy after lung cancer surgery can help prevent the cancer from coming back. It is designed for people with early-stage non-small cell lung cancer who have already had chemotherapy.
This trial tests whether adding electroacupuncture (a gentle, needle-based therapy) to a standard immunotherapy drug (PD-1 inhibitor) can help older adults with advanced lung cancer. It may improve treatment response and quality of life.
This trial tests whether combining electroacupuncture with self-acupressure can improve quality of life for people with early-stage breast cancer during chemotherapy. The treatment is non-invasive and aims to reduce side effects.
This trial tests if acupuncture can prevent nerve damage caused by certain chemotherapy drugs. It is for people with early-stage breast, stomach, colon, lung, or ovarian cancer who have not had nerve symptoms before.
This study tests whether adding electro-acupuncture (a gentle type of acupuncture with mild electrical pulses) to standard first-line immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. It aims to see if this combination improves quality of life and overall treatment outcomes.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.